VE
Live price temporarily unavailable.
Vera Therapeutics Inc Class a (VERA) is a Health Care company in the Russell 2000. Latest news and coverage below.
IPO: May 14, 2021 · $11.00 offering · NASDAQ · View IPO details →
Recent News (20)
-
Trump: ‘Critically important’ CFTC has exclusive authority over prediction markets President Trump on Tuesday said it was “critically important” for the Commodity Futures Trading Commission (CFTC) to maintain exclusive authority over prediction markets, following several lawsuits ag…
-
Florida judge blocks effort to halt new GOP House map A Florida judge on Tuesday blocked an effort to temporarily halt the use of a new Republican-favored House map in the Sunshine State, delivering another blow to Democrats after another judge denied a …
-
Tony Blair’s essay on Labour failings gets full marks for being unhelpful
Intervention by former PM almost feels designed to inflict maximum annoyance on his party
Tony Blair tells Starmer and rivals: abandon net zero and move closer to Trump
Did Tony Blair ever mention h…
-
U.S. stocks mixed at close of trade; Dow Jones Industrial Average down 0.23% U.S. stocks mixed at close of trade; Dow Jones Industrial Average down 0.23%
-
Judge rejects challenge to block new GOP-favored House map in Tennessee A federal judge rejected a challenge to temporarily block a new set of GOP-favored congressional lines in Tennessee on Tuesday, delivering a blow to Democrats who are all but expected to appeal the ru…
-
-
UFC ring construction work starts at White House to celebrate Trump's birthday Construction began this week on a temporary octagon on the White House grounds in preparation to host several UFC fights on Flag Day, which is also President Trump’s 80th birthday. Photos taken by The…
-
Analysts see limited upside to Ackman’s Pershing Square as they kick off coverage
Analysts see limited upside to Ackman’s Pershing Square as they kick off coverage
-
BP chair removed over ‘unacceptable’ governance oversight and conduct issues; UK petrol prices hit new Iran war high – as it happened
Rolling coverage of the latest economic and financial news
Full story: BP removes chair Albert Manifold over ‘serious’ governance and conduct concerns
Middle East crisis live: US attacks Iran missil…
-
-
-
Trump disapproval averaging 58.3 percent, his lowest as president President Trump on Monday hit a disapproval rating of 58.3 percent, the lowest of his two terms as president, according to a new average of polls. That number, calculated by RealClearPolitics (RCP), i…
-
Analyst Initiates Coverage of NextDecade (NEXT) with Buy Rating, $11 Price Target Analyst Initiates Coverage of NextDecade (NEXT) with Buy Rating, $11 Price Target
-
RBC Capital Resumes Coverage of Danaher Corporation (DHR) RBC Capital Resumes Coverage of Danaher Corporation (DHR)
-
Intuitive Surgical (ISRG) Announces Several Innovations to Advance Quintuple Aim Intuitive Surgical (ISRG) Announces Several Innovations to Advance Quintuple Aim
-
UBS initiates Dave stock coverage with buy rating on growth outlook
UBS initiates Dave stock coverage with buy rating on growth outlook
-
RBC Capital initiates Pershing Square stock coverage at Sector Perform
RBC Capital initiates Pershing Square stock coverage at Sector Perform
-
KeyBanc initiates Circle Internet stock coverage at Sector Weight
KeyBanc initiates Circle Internet stock coverage at Sector Weight
-
Goldman Sachs initiates Seaport Therapeutics stock coverage citing platform validation
Goldman Sachs initiates Seaport Therapeutics stock coverage citing platform validation
-
Morgan Stanley initiates Avalyn Pharma stock coverage with overweight rating
Morgan Stanley initiates Avalyn Pharma stock coverage with overweight rating